We developed light-triggered liposomes incorporating gold nanoparticles and Rose Bengal (RB), a well-known photosensitizer used for photodynamic therapy. Singlet oxygen generated by these liposomes with 532 nm light illumination was characterized by adjusting the molar ratio of lipids and gold nanoparticles while keeping the amount of RB constant. Gold nanoparticles were found to enhance the singlet oxygen generation rate, with a maximum enhancement factor of 1.75 obtained for the molar ratio of HSPC: PE-NH 2 : gold of 57:5:17 compared with liposomes loaded with RB alone. The experimental results could be explained by the local electric field enhancement caused by gold nanoparticles. We further assessed cellular cytotoxicity of these liposomes by encapsulating an antitumor drug, doxorubicin (Dox); such Dox loaded liposomes were applied to human colorectal cancer cells, HCT116, and exposed to light. Gold-loaded liposomes containing RB and Dox where Dox release was triggered by light were found to exhibit higher cytotoxicity, compared to the liposomes loaded with RB and Dox alone. Our results indicate that gold-loaded liposomes incorporating photosensitizers may have improved therapeutic efficacy in photodynamic therapy and chemotherapy.
INTRODUCTION
Photodynamic therapy (PDT) is a clinically approved cancer therapy which combines visible light and photosensitizers. Due to its advantages such as minimal toxicity of photosensitizers, low invasiveness and precise targeting, PDT is applicable to the treatment of cancer, infections and age-related macular degeneration 1 . The mechanism by which PDT acts is based on generation of cytotoxic singlet oxygen ( 1 O 2 ) and other reactive oxygen species (ROS) 2, 3 . Upon light excitation the light energy absorbed by photosensitizers is transferred to the surrounding oxygen molecules, causing the formation of 1 O 2 and/or other ROS. These may damage the plasma membranes and DNA, eventually resulting in cell death 4, 5 . Therefore, generation of sufficient amounts of 1 O 2 or other ROS in PDT is a key factor for an effective PDT treatment.
There is intense research interest in the use of gold nanomaterials of varying morphologies to enhance generation of 1 O 2 and other ROS from photosensitizers. Such nanomaterials are characterised by their distinctive surface plasmon resonance (SPR) inducing a strong electromagnetic field around nanostructures when illuminated by light at an appropriate wavelength 6, 7 . The efficacy improvements of PDT using gold nanomaterials were reported by several groups who used gold nanocages conjugated with 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide (HPPH) 8 , gold nanorod core-silica shell incorporating porphyrin molecules 9 , gold nanoparticle/ZnO nanorod hybrids 10 and gold nanoparticles conjugated with 5-aminolevulinic acid (5-ALA) 11 , to name just a few.
It is worth noting that gold nanostructures can also be used to enable the control of drug release from the liposomes. This is because gold nanoparticles convert light absorbed by the SPR into heat via nonradiative processes 12, 13 . This effect enables the control over drug release from the liposomes. Here, the leading approach involves coating of liposome-based delivery platform with gold nanostructures 14, 15 . In this scenario, liposomes illuminated with laser light (NIR lasers in most cases), experience a temperature rise causing a phase transition in the lipids which induces drug release. Additionally, the same gold nanostructures may enable photothermal therapy of cancer. For example, Gao's group A 532nm laser A liposome whose bilayer was loaded with gold and a middle core loaded with RB and Dox
Cancer cell before treatment
Cancer cell after treatment demonstrated rapid drug release from gold-coated liposomes triggered by light irradiation with a 808nm laser, and an enhanced antitumor effect 16 . In addition to coating with gold nanostructures, very small gold nanoparticles encapsulated inside a liposomal bilayer have also been shown to trigger the lipid phase transition via the photothermal effect, leading to the release of liposome contents 17, 18 . It should be mentioned that the small size nanoparticles (< 5.5 nm) used in the latter approach are more advantageous for clinical use than the larger nanostructures generally used for liposome coating, because such small sizes are generally compatible with renal clearance 19, 20 .
In the publications mentioned above, liposomes incorporating very small gold nanoparticles usually require UV irradiation (250 nm) to trigger photothermal release, resulting in potential phototoxicity to tissues 21 , as well as suffering from limited UV penetration depth. In the present work, we attempted to trigger the content of liposomes by using photosensitizers in combination with gold nanoparticles through a photodynamic mechanism where the photosensitizers generate 1 O 2 and other ROS following light irradiation at a wavelength coinciding with the absorption band of photosensitizers. Since most of photosensitizers can be activated with visible light irradiation 22 , this strategy would reduce phototoxicity of light sources currently used for content release from liposomes incorporating small gold nanoparticles.
To this aim, we developed gold-loaded liposomes where 3-5 nm gold nanoparticles were loaded inside a liposomal bilayer. Rose Bengal (RB), a photosensitizer for PDT treatment in breast cancer and metastatic melanoma 23 , was encapsulated inside the cavity of these liposomes (Fig.1) ) for different illumination periods (1, 2, 3, 4, 5 and 6 min) was assessed by using the Singlet Oxygen Green Sensor (SOSG). For comparison, the capabilities of 1 O 2 formation using gold-coated liposomes containing RB were also examined under the same experimental conditions. Furthermore, we demonstrated that these gold-loaded liposomes incorporating a mixture of RB and an antitumor drug doxorubicin (Dox) can also release their content when illuminated by light at 532 nm wavelength. The cytotoxicity assessment in human colorectal cancer cells, HCT116 showed that this was a more effective combination than PDT and standard chemotherapy when applied separately. Figure 1 The scheme of Liposomes containing RB and Dox exhibited higher cancer cell-killing effect under 532nm laser illumination by introducing gold nanoparticles with the optimised amount into a liposomal bilayer.
METHODOLOGY

Materials
Hydrogenated Soy L-α-phosphatidylcholine (HSPC) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(hexanoylamine) (PE-NH2) were purchased from Avanti Polar Lipids. RB, chloroform, sodium hydroxide, gold (III) chloride trihydrate, Triton X-100, hydroxylamine hydrochloride, nitric acid, hydrochloric acid, ammonium sulphate, Dox, dodecanethiol functionalized gold nanoparticles were purchased from Sigma-Aldrich. PBS (pH 7.4) and fetal bovine serum (FBS) were obtained from Thermo Fisher. Singlet Oxygen Sensor Green (SOSG) was supplied from Thermo Fisher Scientific Inc. CellTiter 96® AQueous One Solution Cell Proliferation Assay was purchased from Promega.
Preparation of two types of liposomes incorporating RB: gold-loaded and gold-coated liposomes
The gold-loaded liposomes were prepared by a co-extrusion method with some modification 24 .The mixture of HSPC, PE-NH 2 and gold nanoparticles at different molar ratios was diluted to 1.0 mL in total volume using chloroform in a glass test tube and it was vortexed gently for 10 min. Chloroform was evaporated off with a stream of Argon and the lipid film was formed around the tube wall. This film was hydrated with 1.0 mL of RB solution (0.04 mM), followed by vigorous stirring until the suspension was homogenized. The suspension was extruded eleven times in an extruder (Avanti Polar Lipids, Inc) with two 1.0 mL glass syringes. The pore size of the polycarbonate membrane (Avanti Polar Lipids, Inc) was 100 nm. The resulting suspension was purified by centrifugation (7000 rpm, 10 min) for three times and was stored at 4 °C for further use. Gold-coated liposomes used for comparison were synthesized by using a deposition -precipitation protocol 25 . Briefly 200 μL of RB-loaded liposome suspension was mixed with 90 μL of gold ion solution and diluted to 1.0 mL in total volume using DI water. The mixture was aged for 10 min at room temperature, followed by adding 140 μL of hydroxylamine hydrochloride (20 mM) as a reducing agent. This produces an abrupt colour change of suspension from dark pink to dark purple. The liposome suspension was purified three times by centrifugation at 7000 rpm for 10 min.
Preparation of gold-liposomes nanocomposites containing Dox
Liposomes loaded with Dox inside the liposomal cavity were prepared by using a gradient exchange method at a mass ratio of 1:10 (drug to lipid) with slight difference 26 . 1 mL of ammonium sulphate (250 mM) containing RB (0.04 mM) was used to hydrate the lipid film. After hydration and extrusion, free ammonium sulphate and RB were removed by dialysis of liposome suspension against PBS (pH 7.4) with four buffer changes. Dox solution (10 mg/mL) was subsequently added to liposome suspension, followed by incubation for 1hour at 60 o C. The resulting solution was then dialyzed against PBS (pH 7.4) with four buffer changes to eliminate unloaded Dox.
Characterization of gold-liposome nanocomposites
The extinction spectra of different gold-liposome nanocomposite samples were measured using a spectrophotometer (Cary 5000 UV-Vis-NIR, Varian Inc.). The luminescence spectrum of RB encapsulated inside the liposomes was obtained using a Fluorolog-Tau-3 system from HORIBA Scientific with 450W Xe lamp excitation. Size distribution and zeta potential of liposome samples were measured with a Zetasizer Nano Series from Malvern Instruments. The morphology of liposome-gold nanocomposites was determined using Transmission Electron microscopy (TEM). The airdried samples were imaged using a PHILIPS CM 10 system at an accelerating voltage of 100 KV. Images were captured with an Olympus Megaview G10 camera and iTEM software. To determine encapsulation efficiency of RB and Dox loaded inside liposomes, Triton X-100 (0.1%) was added to as-prepared liposome suspension, resulting in release of RB and Dox. The RB fluorescence (Ex/Em: 525 nm/564 nm) and Dox fluorescence (Ex/Em：485/590 nm) was recorded on a Fluorolog-Tau-3 system and compared with the corresponding RB and Dox standard curve, respectively.
Serum stability of liposomes incorporating RB
200 µL liposome suspension was diluted in PBS (pH 7.4) containing 10% FBS and dialyzed again PBS (pH 7.4) for 48 hours at 37°C. At various time points (0 hr, 2 hr, 4 hr, 18 hr, 24 hr and 48 hr), an aliquot of PBS was taken for the fluorescence characterisation of the released RB. The total RB fluorescence was measured by disrupting liposomes with 0.1% Triton X-100. The percentage of RB release ( ) at various time points was calculated as follows:
where and respectively indicates the RB fluorescence intensity at various incubation time points. refers to the total RB fluorescence intensity after the disruption of liposomes.
Singlet oxygen generation assays
SOSG was used to detect singlet oxygen generated from RB loaded inside liposome-gold nanocomposites. The mixture of 5 µL SOSG (0.5 mM) and 700 µL liposome suspension was placed in a cuvette and it was irradiated with a 532nm continuous wavelength laser (37.9 mW/cm 2 , irradiation for 6 min). After irradiation, the SOSG fluorescence at 525 nm upon 488 nm excitation was recorded using a Fluorolog-Tau-3 system. 
Studies of cellular cytotoxicity of light-triggered gold-liposome nanocoposites containing RB and Dox
Before treatment, HCT116 cells were grown on 96-well plates for 24 hours in culture medium and incubated with liposome samples at different lipid concentration for 4 h. After old medium was removed and fresh medium was added to cells, all cell groups were irradiated with a 532nm laser for 6 min (14.3 mW/cm 2 ), except for the group incubated with liposomes loaded with Dox alone. After irradiation, cells were further incubated for another 24 h prior to cell viability assessment by the MTS assay (Promega Co., WI, USA). Cell viability was calculated as a percentage of the absorption intensity of the control group, which was set to 100%. CCD 841 CoN cells (2×10 4 per well) were grown on 96-well plates for 24 h in culture medium. Cells were then incubated with gold-loaded liposomes containing RB and Dox at two concentration of lipids (45 and 4.5 µg/mL) for 4 h, followed by another 24h incubation in fresh medium. The toxicity of gold-loaded liposomes on CCD 841 CoN cells was determined by the MTS test described as above. Figure 2a shows the TEM image of gold-loaded liposomes where gold nanoparticles were clearly observed due to the higher electron density of gold. Figure 2b shows the absorption spectra of gold-loaded liposomes and RB-loaded liposomes. Gold nanoparticles in these liposomes are responsible for the SPR band maximum around 556 nm, which largely coincides with the absorption band of RB. The liposomes exhibited negative surface charges lower than -30 mV, indicating high stability in the aqueous solution. Additionally, we estimated the encapsulation efficiency of RB and Dox loaded inside liposomes, which was approximately 88.0% and 23.4%, respectively. We also calculated the number of gold nanoparticles per gold-loaded liposome with a molar ratio (HSPC: PE-NH 2 : gold) of 57: 5: 17, which was about 109 as indicated by the ICP-MS data of gold anions in the sample solution. The morphology and absorption spectrum of the gold-coated liposomes also synthesized in this study for comparison with gold-loaded liposomes are shown in Fig. 2c . In these gold-coated liposomes shell-like gold nanostructures coated on the liposomal surface were formed by the interaction between amine group of lipids and gold anions in solution, followed by reduction to gold nanoparticles which function as nucleation sites for the additional gold to be added on to eventually form a shell 25 . The SPR band of gold nanostructures in this case was shifted towards the longer wavelength region, with a maximum at 682 nm, reflecting a strong dependence of the SPR band in gold nanomaterials is on their size and shape 27 . The cumulative percentage of RB released from liposomes (57:5:17) was shown in Fig. 3 . Different amounts of RB were released during 48 hr incubation in PBS with 10% FBS, with about 28% of RB released at 48 hr. It should be mentioned that fast RB release was observed within 4 hr and followed by sustained release till 48 hr. This could be attributed to a burst release of RB loosely bound to the liposome surface in the beginning. a c 
RESULTS AND DISCUSSION
Characterization of gold-liposome nanocomposites
Evaluation of singlet oxygen generation from gold-liposome nanocomposites in solution
We assessed where and represent the reaction rates of the fluorescent detection probe with singlet oxygen generated from RB and a reference photosensitizer respectively. and indicate the transmittance of RB and the reference photosensitizer at the illumination wavelength respectively. We estimated of RB in this liposome formulation to be 1.33±0.27. This value indicates an enhancement factor of 1.75 compared with liposomes loaded with RB alone. The mechanism of this enhancement is related to the enhanced local field around gold nanoparticles induced by their SPR which helps to increase the net system absorption. This, in turn, increases the triplet yield of the photosensitizer, subsequently increasing 1 O 2 generation 30 . Similarly, in our previous research on gold-RB conjugates we also observed enhancement of 1 O 2 formation when excited at 532 nm, compared to RB alone 29 . For comparison, the assessment of 1 O 2 generation from gold-coated liposomes was also performed under the same experimental conditions. Compared with liposomes loaded with RB alone, no increase in the amount of 1 O 2 generated from gold-coated liposomes was observed after 6-min illumination at 532 nm wavelength (Fig.5 ). This could be attributed to photothermal properties of gold nanoshells coated on the liposomal surface that induced conversion of absorbed light into heat 14 . Figure 5 . The increase percentage of SOSG fluorescence intensities in gold-coated liposomes exposed to a 532nm laser at different illumination time points.
In vitro cellular cytotoxicity and dark cytotoxicity of gold-loaded liposomes containing RB and Dox
Considering that drugs would be released from liposomes and subsequently execute their action in a light-triggering modality 33, 34 , we encapsulated Dox inside gold-loaded RB-containing liposomes and examined the cytotoxicity of released Dox in HCT116 cells following light illumination. In this way, we expect that combination with chemotherapy and gold nanoparticle-mediated PDT will be able to produce the enhanced cancer cell-killing efficacy. As shown in Fig.  6a , the cell mortality clearly increased when the cancer cells were treated with gold-loaded liposomes containing RB and Dox (gold-loaded liposomes + RB + Dox) and illuminated with light for 6 min, with a maximum of 38% cells killed at lipid concentration of 15.7 µg/mL. Their cell-killing efficacy was more efficient than liposomes loaded with RB and Dox but without gold doping (liposomes + RB + Dox), which induced only 20% cell death at the same lipid concentration. To confirm this higher cell-killing efficacy was due to combination of gold nanoparticle-mediated PDT and chemotherapy, we also separately assessed cell-killing effect of gold-loaded liposomes containing RB (gold-loaded liposomes + RB) following light illumination and liposome-formulated Dox (liposomes + Dox) without light illumination in cells by varying concentration of liposomes. In this case, only about 28% and 20% of cell mortality was respectively observed at lipid concentration of 15.7 µg/mL (Fig. 6a) . Although 1 O 2 generation from gold-coated liposomes containing RB was not observed in our study, there was evidence in literature that photothermal therapy (PPT) induced by gold nanostructures coated on the liposomal surface can damage cancer cells due to local thermal heating 15, 35 . Therefore we examined the cell-killing effect of gold-coated liposomes after laser irradiation. As shown in Fig.6b , the cell viability was not obviously changed after treatment with gold-coated liposomes containing RB (gold-coated liposomes + RB) and light illumination. It must be taken into account that PPT requires a good overlap between absorption band of gold nanostructures and laser excitation wavelength to achieve sufficient photothermal transduction. In our case, the absorption band of gold coating on the liposome surface did not perfectly coincide with excitation light, resulting in minimal energy transformation from light into heat. Similar to the photothermal effect on cell-killing, the heat generated by gold nanostructures after light irradiation also can cause gel-toliquid phase transition of lipids, triggering drug release from liposomes. Therefore we evaluated if gold coating can trigger a massive drug release from liposomes upon laser irradiation. This was done by assessment of cell viability treated with gold-coated liposomes containing RB and Dox (gold-coated liposomes + RB + Dox) under the same experimental conditions. As shown in Fig.6b , there was still no clear increase in cellular cytotoxicity after treatment, indicating negligible leakage of Dox from liposomes after 532nm irradiation. As we know, the phase transition temperature of HSPC and PE-NH 2 used in this study was above 45 °C 36, 37 , which requires sufficient photothermal heat generation from gold nanostructures to trigger lipid phase transition. To this end, we checked if the temperature of goldcoated liposome suspension was increased above 45°C after 6-min light illumination and found out it was not obviously changed, indicating that gold nanoshells did not contribute to generation of sufficient heating for lipid transition and drug release under 532nm laser illumination. The biocompatibility test of gold-loaded liposomes containing RB and Dox was performed by evaluation of their dark cytotoxicity on normal human colon cells (CCD 841 CoN). Cell viability did not show noticeable reduction after treatment of these liposomes at two concentration of lipids (45 and 4.5 µg/mL), compared with the control group (Fig. 7) .
Our results indicate that under in vitro conditions, gold-loaded liposomes are likely not to affect the viability of CCD 841 CoN cells. 
CONCLUSIONS
In this study we developed gold-loaded liposomes containing a photosensitizer RB. We compared their capability for 1 O 2 generation enhancement by changing the amount of gold nanoparticles used in the liposome formulation. A maximum enhancement factor of 1.75 was achieved when the molar ratio of HSPC: PE-NH 2 : gold was 57:5:17 and illuminated at 532 nm wavelength for 6 min. We calculated relative singlet oxygen quantum yield of RB encapsulated in this formulation which was 1.33 ± 0.27. We further assessed cellular cytotoxicity of gold-loaded liposomes containing RB and Dox in HCT116 cells at 532 nm illumination. They exhibited higher cell-killing efficacy compared with liposomes containing RB and Dox alone under the same experimental conditions. These results indicate gold nanoparticles encapsulated inside liposomes can contribute to enhanced 1 O 2 generation and triggered drug release can be induced by this liposome platform with light illumination. The combination of gold nanoparticle-mediated PDT and concurrently triggered chemotherapy may have potential to be used for improved cancer treatment.
